1,092
Participants
Start Date
February 17, 2022
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
Investigational products administration
"Investigational products include:~* Hydrocortisone hemisuccinate 50 mg: one intravenous injection every 6 hours, and~* 9 alpha fludrocortisone 50 μg: one tablet per day via a nasogastric tube.~All treatments will be stopped after 7 days or until the patient has left the intensive care unit (whichever occurs first) without tapering off."
Placebo administration
Placebos for hydrocortisone and for fludrocortisone, administered in same manner as the active drugs in the interventional arm, for 7 days.
RECRUITING
General Intensive care Unit, Raymond Poincaré Hospital, APHP, Garches
Assistance Publique - Hôpitaux de Paris
OTHER